Natera (NTRA) Files $100M IPO

Natera, Inc. (Nasdaq: NTRA) filed a registration with the U.S. SEC for an IPO of its Common Stock. The proposed maximum offering price is $100 million. The company plans to list on the Nasdaq Global Market under the ticker, "NTRA."

Underwriters are Morgan Stanley, Cowen and Company, Piper Jaffray, Baird, and Wedbush Pacgrow.

Revenue was $159.3 million in FY14 with net loss of $0.66 per share, from revenue of $55.2 million and net loss of $5.93 per share reported in the prior year. For forma loss in 2014 was $0.10 per share.

Natera is a rapidly growing diagnostics company with proprietary molecular and bioinformatics technology that we are deploying to change the management of genetic disease worldwide.

You May Also Be Interested In

• YY Group Holding (YYGH) Closes $5M IPO
• Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
• CSS Entertainment (CSSE) Receives Nasdaq Delinquency Letter